Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,838 | 20,171 | 15,328 | 8,437 | 13,155 |
| Receivables | 226 | 248 | 162 | 142 | 202 |
| TOTAL | $21,111 | $22,791 | $16,820 | $9,297 | $14,297 |
| Non-Current Assets | |||||
| PPE Net | 94 | 101 | 85 | 102 | 118 |
| TOTAL | $94 | $101 | $85 | $102 | $118 |
| Total Assets | $21,205 | $22,892 | $16,905 | $9,399 | $14,415 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,707 | 2,493 | 2,490 | 2,361 | 5,775 |
| Other current liabilities | 1,064 | 2,673 | 1,530 | N/A | N/A |
| TOTAL | $3,802 | $5,195 | $4,047 | $2,388 | $5,801 |
| Non-Current Liabilities | |||||
| TOTAL | $47 | $56 | $62 | $71 | $77 |
| Total Liabilities | $3,849 | $5,251 | $4,110 | $2,459 | $5,878 |
| Shareholders' Equity | |||||
| Common Shares | 159,633 | 155,112 | 144,476 | 136,007 | 129,807 |
| Retained earnings | -166,110 | -163,195 | -152,496 | -149,466 | -141,633 |
| Other shareholders' equity | 2,037 | 2,056 | 0 | 0 | 0 |
| TOTAL | $17,356 | $17,642 | $12,795 | $6,940 | $8,537 |
| Total Liabilities And Equity | $21,205 | $22,892 | $16,905 | $9,399 | $14,415 |